Prognostic value of UPA, PAI-1, and PAI-2 mRNA expression in primary breast cancer.

被引：0
|
作者：
Spyratos, F
Bouchet, C
Tozlu, S
Labroquère, M
Vignaud, S
Becette, V
Lidereau, R
Bièche, I
机构：
[1] Ctr Rene Huguenin, St Cloud, France
[2] Fac Sci Pharmaceut & Biol Paris, Genet Mol Lab, Paris, France
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2001年 / 69卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
323
引用
收藏
页码：262 / 262
页数：1
相关论文
共 50 条
  • [1] Prognostic value of uPA, PAI-1 and PAI-2 mRNA expression in primary breast cancer
    Spyratos, F
    Bouchet, C
    Tozlu, S
    Labroquere, M
    Vignaud, S
    Becette, V
    Lidereau, R
    Bieche, I
    ANTICANCER RESEARCH, 2002, 22 (05) : 2997 - 3003
  • [2] Prognostic value of uPA and PAI-l mRNA expression in primary breast cancer.
    Verjat, T
    Lamy, PJ
    Grenier, J
    Servanton, AC
    Paye, M
    Krause, A
    Bachelot, T
    Puisieux, A
    Mougin, B
    Leissner, P
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S132 - S132
  • [3] Predictive value of PAI-1 and PAI-2 in breast cancer
    Matos, E
    Vrhovec, I
    Borstnar, S
    Jagodic, M
    Cufer, T
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S111 - S111
  • [4] PAI-1 polymorphism and expression of uPA, PAI-1 and COX-2 in breast cancer.
    Minisini, AM
    Di Loreto, C
    Pestrin, M
    Fabbro, D
    Cardellino, GG
    Russo, S
    Andreetta, C
    Damante, G
    Piga, A
    Puglisi, F
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 879S - 879S
  • [5] Prognostic and predictive value of the urokinase-type plasminogen activator (uPA) and its inhibitors PAI-1 and PAI-2 in operable breast cancer
    Cufer, T
    Borstnar, S
    Vrhovec, I
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2003, 18 (02): : 106 - 115
  • [6] PAI-1 and PAI-2 as predictive factors in breast cancer
    Matos, E.
    Borstnar, S.
    Vrhovec, I.
    Svetic, B.
    Cufer, T.
    EJC SUPPLEMENTS, 2004, 2 (03): : 181 - 182
  • [7] Role of uPA and PAI-1 mRNA expression as prognostic factors in molecular subtypes of breast cancer
    Witzel, I.
    Milde-Langosch, K.
    Schmidt, M.
    Karn, T.
    Rody, A.
    Wirtz, R.
    Jaenicke, F.
    Mueller, V.
    CANCER RESEARCH, 2013, 73
  • [8] Prognostic importance of the uPA/PAI-1 complex in breast cancer
    Sten-Linder, M
    Seddighzadeh, M
    Engel, G
    Rutqvist, LE
    Linder, S
    Skoog, L
    Wiman, B
    ANTICANCER RESEARCH, 2001, 21 (4B) : 2861 - 2865
  • [9] PROGNOSTIC VALUE OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (UPA) AND PLASMINOGEN-ACTIVATOR INHIBITORS PAI-1 AND PAI-2 IN BREAST CARCINOMAS
    BOUCHET, C
    SPYRATOS, F
    MARTIN, PM
    HACENE, K
    GENTILE, A
    OGLOBINE, J
    BRITISH JOURNAL OF CANCER, 1994, 69 (02) : 398 - 405
  • [10] Prognostic and predictive impact of uPA/PAI-1 in early breast cancer
    Wieder, V.
    Engel, J.
    Bauer, M.
    Kaufhold, S.
    Hanf, V.
    Uleer, C.
    Lantzsch, T.
    Peschel, S.
    John, J.
    Poehler, M.
    Weigert, E.
    Burrig, K-F.
    Buchmann, J.
    Kantelhardt, E.
    Thomssen, C.
    Vetter, M.
    ANNALS OF ONCOLOGY, 2023, 34 : S297 - S297
12345